Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 280,262 |
|
|||||
| News | - | ||||||
| Day High | 2.63 | Low High |
|||||
| Day Low | 2.2501 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| NovaBay Pharmaceuticals Inc New | NBY | AMEX | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.37 | -14.40% | 2.20 | 09:59:10 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.61 | 2.2501 | 2.63 | 2.30 | 2.57 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,060 | 280,262 | US$ 2.40 | US$ 673,033 | - | 2.2301 - 44.80 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 10:00:00 | 809 | US$ 2.30 | USD |
NovaBay Pharmaceuticals Inc New Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 14.95M | 6.53M | - | 14.73M | -16.7M | -2.56 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
NovaBay Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 14/6/2024 | 22:47 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07/6/2024 | 21:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07/6/2024 | 20:50 | Business Wire | NovaBay Pharmaceuticals Plan of Compliance Accepted by the.. |
| 01/6/2024 | 06:50 | Edgar (US Regulatory) | Form 8-K - Current report |
| 01/6/2024 | 06:43 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
| 31/5/2024 | 11:31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 31/5/2024 | 11:29 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 31/5/2024 | 11:27 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 31/5/2024 | 11:24 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 31/5/2024 | 11:17 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 30/5/2024 | 07:27 | Edgar (US Regulatory) | Form 8-K - Current report |
| 30/5/2024 | 07:22 | Business Wire | NovaBay Pharmaceuticals Announces Approval of All Proposals.. |
Historical NBY Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.83 | 3.14 | 2.2301 | 2.57 | 279,517 | -0.63 | -22.26% |
| 1 Month | 5.25 | 6.30 | 2.2301 | 4.89 | 6,880,500 | -3.05 | -58.10% |
| 3 Months | 4.592 | 9.079 | 2.2301 | 4.71 | 9,747,410 | -2.39 | -52.09% |
| 6 Months | 10.115 | 10.15 | 2.2301 | 5.00 | 6,152,960 | -7.92 | -78.25% |
| 1 Year | 24.15 | 44.80 | 2.2301 | 6.75 | 3,395,379 | -21.95 | -90.89% |
| 3 Years | 866.565 | 1,074.57 | 2.2301 | 161.09 | 1,700,043 | -864.37 | -99.75% |
| 5 Years | 1,984.50 | 2,744.00 | 2.2301 | 746.44 | 2,064,819 | -1,982.30 | -99.89% |
